Skip to main content
Premium Trial:

Request an Annual Quote

M2Gen Oncology-Focused Bioinformatics Support Services

M2Gen has launched oncology-focused bioinformatics support services. Leveraging the results and knowledge gained from the Orien Avatar Program, an oncology clinic-genomics dataset, M2Gen offers bioinformatics services that include paired tumor and germline whole-exome sequencing (WES) analysis with panels-of-normal filtering; tumor-only WES analysis with virtual-normal somatic mutation classification; and tumor-only RNA sequencing analysis. M2Gen said that pipeline analysis is WES and RNA-seq capture kit-agnostic, and uses the most up-to-date human genome reference and gene build.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.